1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 30
2.3 Market Restraints and Challenges 38
2.4 Emerging Opportunities and Market Trends 41
2.5 Porters Fiver Forces Analysis 45
3 Segmentation of North America Market by Synthesis 49
3.1 Market Overview by Synthesis 49
3.2 Synthetic API 51
3.2.1 Branded Synthetic API 52
3.2.2 Generic Synthetic API 53
3.3 Biotech API 54
3.3.1 Biotech API by Drug Type 55
3.3.1.1 Monoclonal Antibodies 56
3.3.1.2 Recombinant Proteins 57
3.3.1.3 Vaccines 58
3.3.1.4 Other Biotech APIs 59
3.3.2 Biotech API by Category 60
3.3.2.1 Innovative Biologic API 61
3.3.2.2 Generic Biosimilar API 62
3.3.3 Biotech API by Expression Technology 63
3.3.3.1 Mammalian Expression 64
3.3.3.2 Microbial Expression 65
3.3.3.3 Yeast Expression 66
3.3.3.4 Insect Expression 67
3.3.3.5 Other Expression Technologies 68
3.4 HPAPI 69
3.4.1 Branded HPAPI 70
3.4.2 Generic HPAPI 71
4 Segmentation of North America Market by Manufacturing Process 72
4.1 Market Overview by Manufacturing Process 72
4.2 Captive Manufacturing 74
4.2.1 Branded Captive API 75
4.2.2 Generic Captive API 76
4.3 Merchant Manufacturing 77
4.3.1 Merchant Manufacturing by Drug Type 78
4.3.1.1 Branded Merchant API 79
4.3.1.2 Generic Merchant API 80
4.3.2 Merchant Manufacturing by Drug Synthesis 81
4.3.2.1 Merchant Synthetic API 82
4.3.2.2 Merchant Biotech API 83
5 Segmentation of North America Market by Therapeutic Application 84
5.1 Market Overview by Therapeutic Application 84
5.2 Infectious Diseases 86
5.3 Oncology 87
5.4 Ophthalmology 88
5.5 Cardiovascular Disorders 89
5.6 Central Nervous System 90
5.7 Pulmonary Disorders 91
5.8 Orthopedics 92
5.9 Other Applications 93
6 Segmentation of North America Market by Drug Type 94
6.1 Market Overview by Drug Type 94
6.2 Branded Prescription Drugs 96
6.3 Generic Prescription Drugs 97
6.4 OTC Drugs 98
7 North America Market 2021-2028 by Country 99
7.1 Overview of North America Market 99
7.2 U.S. 102
7.3 Canada 113
7.4 Mexico 115
8 Competitive Landscape 117
8.1 Overview of Key Vendors 117
8.2 New Product Launch, Partnership, Investment, and M&A 120
8.3 Company Profiles 121
AbbVie Inc. 121
Astrazeneca 123
Aurobindo Pharma Ltd. 128
BASF 131
Bayer AG 134
Boehringer Ingelheim 138
Catalent Inc. 143
Dr. Reddy's Laboratories 146
F. Hoffmann-La Roche 148
GlaxoSmithKline plc 150
Lonza Group 155
Lupin Limited 160
Merck & Co., Inc. 163
Mylan NV 166
Novartis International AG 169
Pfizer Inc. 172
Sanofi 177
Sun Pharmaceutical Industries Ltd. 180
Teva Pharmaceutical Industries Ltd. 183
Thermo Fisher Scientific 185
9 Investing in North America Market: Risk Assessment and Management 187
9.1 Risk Evaluation of North America Market 187
9.2 Critical Success Factors (CSFs) 190
Related Reports and Products 193